These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 11392161)

  • 1. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group.
    Gumprecht J; Zychma MJ; Grzeszczak W; Zukowska-Szczechowska E
    Kidney Int; 2000 Aug; 58(2):513-9. PubMed ID: 10916074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiotensin converting enzyme (S-ACE) activity in patients with chronic renal failure on regular hemodialysis.
    Miura H; Nakayama M; Sato T
    Jpn Heart J; 1984 Jan; 25(1):87-92. PubMed ID: 6330398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of angiotensin I converting enzyme (ACE) Pst 1 polymorphism in the development of chronic renal failure].
    Gumprecht J; Zychma MJ; Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 2000 Sep; 104(3):555-62. PubMed ID: 11392161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.
    Ha SK
    J Diabetes Res; 2014; 2014():846068. PubMed ID: 25587546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the progression of diabetic nephropathy to renal failure.
    Kikkawa R; Togawa M; Isono M; Isshiki K; Haneda M
    Kidney Int Suppl; 1997 Nov; 62():S39-40. PubMed ID: 9350677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing end stage renal disease in diabetic patients--genetic aspect (part I).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):1-14. PubMed ID: 16088846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.
    Rudnicki M; Mayer G
    Pharmacogenomics; 2009 Mar; 10(3):463-76. PubMed ID: 19290794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme gene polymorphisms and renal disease.
    Jardine AG; Padmanabhan N; Connell JM
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):259-64. PubMed ID: 9617555
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.